Cargando…

1360. Remdesivir in COVID 19 patients with kidney disease: A study on the renal function and outcomes

BACKGROUND: The COVID-19 pandemic has high mortality rates in patients with kidney disease. Remdesivir, an antiviral nucleotide prodrug, showed to shorten time to recovery in adults hospitalized with COVID 19. However, individuals with kidney disease were not included in clinical trials, thus when e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barez, Marie Yvette, Lagura, C R Y S T A L F A Y E G, Ivy, Leano-Togonon Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677041/ http://dx.doi.org/10.1093/ofid/ofad500.1197

Ejemplares similares

1360. Prevalence of Bacteremia in Hospitalized Patients with Skin and Soft Tissue Infections (SSTI)
por: Suarez, Maria J, et al.
Publicado: (2021)

1360. Investigating Transmission Dynamics Between Pets and Caretakers in Households of Children with Methicillin-resistant S. aureus Skin and Soft Tissue Infections
por: Kinzer, Hannah, et al.
Publicado: (2022)

1360. Antimicrobial Activity of Cefepime in Combination with VNRX-5133 Against a Global Collection of Enterobacteriaceae Including Resistant Phenotypes
por: Hackel, Meredith, et al.
Publicado: (2018)

1360. Disseminated Mycobacterium abscessus Infections in Patients with Neutralizing Anti-interferon-gamma Autoantibodies Treated with Rifabutin-based Combination Regimens
por: Cheng, Aristine, et al.
Publicado: (2019)

Riemerella anatipestifer M949_1360 Gene Functions on the Lipopolysaccharide Biosynthesis and Bacterial Virulence
por: Yu, Guijing, et al.
Publicado: (2016)

1360. Variation in Duration of Antibiotic Therapy for Central-line Associated Blood Stream Infections Caused by Gram Negative Bacilli in Hospitalized Children
por: Whitmer, Grant R, et al.
Publicado: (2020)

COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome - a retrospective cohort study
por: Elec, Florin, et al.
Publicado: (2022)

LS2 Dismac project 1360 openings finished in LHC sector 1-2
por: Struik, Michael
Publicado: (2019)

Rhodococcus rhodochrous IEGM 1360, an Effective Biocatalyst of C3 Oxidative Transformation of Oleanane Triterpenoids
por: Luchnikova, N. A., et al.
Publicado: (2023)

Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function
por: Seethapathy, Rituvanthikaa, et al.
Publicado: (2023)

POS-945 THE ROLE OF HEMOPERFUSION AS A COUNTERMEASURE FOR CYTOKINE STORM IN COVID-19 PATIENTS ADMITTED IN A PUBLIC TERTIARY HOSPITAL IN DAVAO CITY
por: IBOT, N.J., et al.
Publicado: (2022)

Liver and kidney function in patients with Covid‐19 treated with remdesivir
por: van Laar, Sylvia A., et al.
Publicado: (2021)

DES c.1360C>T: A Rare Desmin Variant Causing Early Distal Myopathy and Cardiomyopathy
por: Dias, Rafael, et al.
Publicado: (2023)

Remdesivir: First Approval
por: Lamb, Yvette N.
Publicado: (2020)

506. Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19
por: Andreatta, Kristen, et al.
Publicado: (2023)

540. Does Remdesivir Impact the Clinical Outcome of Patients with COVID 19 Infection?
por: Gunasekaran, Karthik, et al.
Publicado: (2021)

550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting
por: Vo, Vinny P, et al.
Publicado: (2023)

73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir
por: Diaz, George, et al.
Publicado: (2020)

1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans
por: Jeyapalina, Sujee, et al.
Publicado: (2022)

541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
por: Platzer, Moritz, et al.
Publicado: (2023)

542. Evaluation of Remdesivir to the Outcomes of Hospitalized Patients with COVID-19 Infection in a Tertiary Care Hospital in Southern India
por: Raju, Jomel, et al.
Publicado: (2023)

518. Comparable Outcomes of Remdesivir and Sotrovimab among High-risk Patients with Mild to Moderate COVID-19 During the Omicron BA.1 Surge
por: Chesdachai, Supavit, et al.
Publicado: (2023)

448. Real World Evaluation of Clinical Outcomes for Short-Duration Remdesivir Therapy in Hospitalized Patients with Mild-Moderate COVID-19
por: Williams, Kelsey N, et al.
Publicado: (2023)

Extracorporeal Membrane Oxygenation in a 1,360-g Premature Neonate after Repairing Total Anomalous Pulmonary Venous Return
por: Rhee, Youn Ju, et al.
Publicado: (2016)

538. Clinical Evaluation of Drug-drug Interactions with Remdesivir
por: Peng, Chi-Chi, et al.
Publicado: (2023)

536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
por: Raffi, François, et al.
Publicado: (2021)

72. Remdesivir vs Standard Care in Patients with Moderate covid-19
por: Marty, Francisco M, et al.
Publicado: (2020)

557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic
por: Xin Liao, J, et al.
Publicado: (2021)

524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies
por: Force, Lindsey, et al.
Publicado: (2023)

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
por: Criner, Gerard J, et al.
Publicado: (2020)

Remdesivir: Kidney disorder : case report
Publicado: (2021)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Remdesivir-related acute kidney injury in patients with COVID-19
Publicado: (2020)

Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
por: Buxeda, Anna, et al.
Publicado: (2021)

555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
por: Caffrey, Aisling, et al.
Publicado: (2021)

POS-026 REMDESIVIR IN PATIENTS WITH ACUTE OR CHRONIC KIDNEY DISEASE IN COVID-19 AND IMPACT ON LIVER FUNCTION
por: Thakur, A., et al.
Publicado: (2022)

474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
por: Hirai, Jun, et al.
Publicado: (2023)

395. Remdesivir Stewardship Through Criteria for Use Implementation Across a Large System is Associated with Enhanced Outcomes and Efficiency
por: Daragjati, Florian, et al.
Publicado: (2023)

544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital
por: Rodriguez, Brittany, et al.
Publicado: (2023)

P1360: CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE
por: Lysandrou, Memnon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ac6epdgsrvbs7prlj6tpl037ce